Patent · US Active

TCRa homing endonuclease variants

US12264343B2 · kind B2 · utility

0Cited by
4References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 24, 2023
Grant dateApr 1, 2025
Priority date
Expiry dateFeb 24, 2043

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure provides improved genome editing compositions and methods for editing a TCRα gene.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.